
Sotrovimab is authorized to treat COVID-19 patients 12 years of age and older with mild-to-moderate infection and who are at high risk for severe disease progression.

Sotrovimab is authorized to treat COVID-19 patients 12 years of age and older with mild-to-moderate infection and who are at high risk for severe disease progression.

A recent test found various brands and batches of sunscreen and after-sun care products contained benzene, a potential carcinogen.

The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Here’s a roundup of the latest coronavirus-related news.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

With all Americans over 12 years able to get vaccinated for COVID-19 and the CDC releasing recent changes to guidelines for fully vaccinated individuals, it’s more important than ever to stay up-to-date on COVID-19 headlines.

The CDC today announced an updated guidance on mask wearing and social distancing for individuals fully vaccinated against COVID-19.

The FDA has expanded the emergency use authorization for the COVID-19 vaccine to include individuals 12 to 15 years of age.

Good Neighbor Pharmacy, AmerisourceBergen’s network of independent community pharmacies, launched a COVID-19 Vaccines Pharmacy Locator Tool on MyGNP.com.

Here’s a roundup of the latest coronavirus-related news.

Pfizer and BioNTech have initiated rolling submission of their Biologics License Application for full approval of BNT162b2.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Here’s a roundup of the latest coronavirus-related news.

Flip the Pharmacy announced the winners of its inaugural Flip the Pharmacy Awards.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

A committee of vaccine advisers to the CDC convened to discuss the risk of a rare blood clotting condition linked to the Johnson & Johnson COVID-19 vaccine.

Here’s a roundup of the latest coronavirus-related news.

Patrick Yoder, PharmD, discusses the impacts of the impending ASHP guideline updates, how to build drug diversion processes, and the ways that technology can target drug diversion.

The European Medicines Agency determined that the benefits of Johnson & Johnson’s COVID-19 vaccine outweigh the risks. The vaccine is still paused in the United States.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Beginning this week, the OTC self-administered rapid antigen test will be available in Walgreens stores for $23.99.

Here's a roundup of the latest coronavirus-related news.

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Here's the roundup of COVID-19 related news from this week.

What workflow is best for your pharmacy team?

Here’s a preview of the featured content to watch for this week on Drug Topics®.

Pharma Logistics announced it has secured the Pharmaceutical Reverse Distribution Program with the Department of Defense.

Here’s a roundup of the latest coronavirus-related news.